Overview

Start or STop Anticoagulants Randomised Trial (SoSTART)

Status:
Completed
Trial end date:
2021-03-26
Target enrollment:
Participant gender:
Summary
Primary research question: For adults surviving spontaneous (non-traumatic) symptomatic intracranial haemorrhage with persistent/paroxysmal atrial fibrillation/flutter (AF), does starting full treatment dose oral anticoagulation (OAC) result in a beneficial net reduction of all serious vascular events compared with not starting OAC? Trial design: Investigator-led, multicentre, randomised, open, assessor-masked, parallel group, clinical trial of investigational medicinal product (CTIMP) prescribing strategies. Investigators plan for a pilot phase, followed by a safety phase.
Phase:
Phase 3
Details
Lead Sponsor:
University of Edinburgh
Collaborator:
NHS Lothian
Treatments:
Acenocoumarol
Anticoagulants
Antithrombins
Apixaban
Dabigatran
Edoxaban
Factor Xa Inhibitors
Phenindione
Platelet Aggregation Inhibitors
Rivaroxaban
Warfarin